COVID-19 impact on blood vessels and heart health

blood vessels and heart health

COVID-19 may have long-term impact on blood vessels and heart health: New research published in Experimental Physiology highlight the possible long term health impacts of COVID-19 on young, relatively healthy adults who were not hospitalized and who only had minor symptoms due to the virus. Increased stiffness of arteries in particular was found in young adults, which […]

Read More… from COVID-19 impact on blood vessels and heart health

Manufacturing Australian medical devices

medical devices

Australian medical devices manufacturing facility first: The launch of Australia’s first medical device development and manufacturing facility in Melbourne is set to fast-track new treatments for people with conditions such as epilepsy, Parkinson’s disease, hearing loss, stroke and diabetes. The new facility called Neo-Bionica, a joint venture between the Bionics Institute and the University of […]

Read More… from Manufacturing Australian medical devices

Covid-19 anxiety syndrome 

anxiety

‘Covid-19 anxiety syndrome’ may cause a significant number of people to struggle with reintegrating back into daily life as UK society returns to normal after the pandemic, says new research by London South Bank University (LSBU), in partnership with Kingston University. The research findings show that one in five of the 286 UK-based survey participants scored highly on the Covid-19 […]

Read More… from Covid-19 anxiety syndrome 

Dementia: Time to implement research findings

dementia research findings

Dementia: Time to implement research findings: The last 20 years has seen significant advancements in our understanding of the human brain and the biology of dementia and other neurodegenerative diseases. However, despite this progress, there remains a lack of societal understanding of dementia and implementation of our knowledge about how to treat it effectively. Recent […]

Read More… from Dementia: Time to implement research findings

New algorithm for the diagnostics of dementia

Brain key algorithm

New algorithm for the diagnostics of dementia: A top-level international research team including researchers from the University of Eastern Finland has developed a new algorithm for the diagnostics of dementia. The algorithm is based on blood and cerebrospinal fluid biomarker measurements. These biomarkers can be used to aid setting of an exact diagnosis already in […]

Read More… from New algorithm for the diagnostics of dementia

Tarantula venom treatment for type 2 diabetes

type 1 diabetes

Tarantula venom could provide new treatment avenue for type 2 diabetes: Research presented at DUKPC 2021 reveals molecules found in tarantula venom could offer promising new treatment option for type 2 diabetes. Molecules found in tarantula venom reduced blood sugar levels and decreased food intake in mice New research presented today at the Diabetes UK […]

Read More… from Tarantula venom treatment for type 2 diabetes

Anaphylactic reactions, lessons learned

anaphylactic

A fifth of all fatal reactions occur while at school: This rise in serious anaphylactic reactions is a huge issue for schools, as they are responsible for the welfare of our children, whilst in their care. We are proud to be working with SAPHNA the Schools and Public Health Nurses Association to help schools provide […]

Read More… from Anaphylactic reactions, lessons learned

Type 2 diabetes diagnosis: over 2 year wait

type 2

UK Biobank study of over 200,000 people reveals an average wait of 2.3 years before type 2 diabetes is diagnosed. Being female, having a lower BMI and lower blood sugar levels were associated with delayed diagnosis. New research presented today at the Diabetes UK Professional Conference (DUKPC) 2021 has revealed that people living with undiagnosed […]

Read More… from Type 2 diabetes diagnosis: over 2 year wait

Type 2 diabetes and dementia

dementia

New research could help find ways to prevent dementia in people with type 2 diabetes New research, presented at DUKPC 2021, finds higher blood pressure and cholesterol levels in people with type 2 diabetes who developed dementia, compared with those who did not, up to 20 years before dementia diagnosis A decline in bodyweight, starting […]

Read More… from Type 2 diabetes and dementia